US-Israel Collaboration to Accelerate Medical Technology and Drug Development.
This Act establishes a program to enhance cooperation between the United States and Israel in the research, development, and manufacturing of innovative medical products, including biological drugs and devices. The goal is to accelerate citizens' access to new, life-saving therapies, reduce production costs, and strengthen the security of essential health product supplies. The program also focuses on regulatory harmonization and telemedicine development.
Key points
Accelerating research on new drugs, vaccines, and medical devices through joint US-Israel research projects.
Supporting the manufacturing of biological products in the US to potentially lower costs and increase supply chain resilience.
Developing telemedicine and digital health solutions, which may improve access to medical care.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.